MURIEL BOWSER
MAYOR
June 15, 2023
The Honorable Phil Mendelson
Chairman
Council
of the District of Columbia
John
A. Wilson Building
1350Pennsylvania Avenue,
NW, Suite 504
Washington, DC 20004
Dear Chairman Mendelson:
In accordance with section 2
ofthe Confirmation Act of 1978, effective March 3, 1979 (D.C. Law
2-142; D.C. Official
Code§ 1-523.01), and pursuant to section 4603 of the Child Fatality Review
Committee Establishment Act
of 2001, effective October 3, 2001 (D.C. Law 14-28; D.C. Official
Code§ 4-1371.03), I am pleased to nominate the following person:
Dr. Jacqueline Francis
12th Street
NE
Washington, D.C. 20002
(Ward
6)
for reappointment as a community representative member of the Child Fatality Review Committee,
for
a term to end July 16, 2025.
Enclosed you will find biographical information detailing the experience
of the above
mentioned nominee, together with a proposed resolution
to assist the Council during the
confirmation process.
I would appreciate the Council's earliest consideration of this nomination for confirmation.
Please do not hesitate
to contact me, or Steven Walker, Director, Mayor's Office of Talent
and Appointments, should the Council require additional information. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
~~~
at the request of the Mayor
A PROPOSED RESOLUTION
IN THE COUNCIL
OF THE DISTRICT OF COLUMBIA
16 To confirm the reappointment of Dr. Jacqueline Francis to the Child Fatality Review Committee.
17
18 RESOLVED, BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this
19 resolution may be cited as the "Child Fatality Review Committee Dr. Jacqueline Francis
20 Confirmation Resolution of 2023".
21
22 Sec. 2. The Council of the District of Columbia confirms the reappointment of:
23
24 Dr. Jacqueline Francis
25 12th Street NE
2.6 Washington, D.C. 20002
27 (Ward 6)
28
29 as a community representative member of the Child Fatality Review Committee, pursuant to
30 section 4603 of the Child Fatality Review Committee Establishment Act of 2001, effective
31 October 3, 2001 (D.C. Law 14-28; D.C. Official Code§ 4-1371.03), and in accordance with
32 section 2 of the Confirmation Act of 1978, effective March 3, 1979 (D.C. Law 2-142; D.C.
33 Official Code§ 1-523.01), for a term to end July 16, 2025.
34 Sec. 3. The Council of the District of Columbia shall transmit a copy of this resolution,
35 upon its adoption, to the nominee and to the Office of the Mayor.
36 Sec. 4. This resolution shall take effect immediately.
37 Jacqueline Nicole Francis, MD, MPH
OBJECTIVES: To serve as a health advocate.
WORKEXPERIENCE
Acting Chief Pediatric Medical Officer Silver Spring, l\,ID .Apr. 2012-2013
Serving
as chief pediatric physician expert in the Center for Devices and Radiological Health. Represents the
Center
on pediatri<:: medical device related issues. Drafting guidance documents related to Pediatric Medical
Device Tracking, Custom Devices,
HDE legislation and Extrapolation of adult data for pediatric device
indications. Coordinates initiatives and oversees execution ofactivities related to pediatric device issues.
Planned and
exe<::uted the Rare Diseases Workshop to address pediatric issues related to the development of
medical devices used for rare diseases Qanuary 8, 2014). Works with the Pediatric Device Consortium (FDA)
to conduct workshops for grant recipients, collaborated
on the drafting of the grant application/FR notice
and will oversee selection
of grant recipients. Represents FD.A and expert on pediatric device development
and regulation.
Medical Officer Silver Spring, MD Sept. 2006-to date
Clinical consultant
to Plastic: Surgery and Reconstruction Branch of the Office of Device Evaluation in the
Center for Devices
and Radiological Health at the Food and Drug ..Administration. This division evaluates
and
dears plastic surgery diagnostic and therapeutic devices. Served as clinical consultant to other branches
for a variety
of devices including neurological, orthopedic, and general surgery devices with pediatric
indications.
Collaborative Reviewer Rockville, MD 2007-2010
Served
as a collaborative reviewer \,Vith the Office of Patient Safety with the Medsun pilot project and
working to launch
KIDNET (adverse event reporting system for pediatric devices). Represented FDA,
Presented abstract poster on the K.IDNET program at the American Academy of Pediatrics Annual meeting
October 2008. to educate pediatricians about the
KIDNET program.
Attending Physician Washington, DC Jan. 2005 to date
KIDS Mobile Medical Clinic pediatrician working in medically underserved areas
of Washington, DC each
Friday as primary pediatrician. Also serving
on the teaching staff supervising training of residents and
medical students. Credentialed at
Georgetown University Hospital.
Medical Officer
Rockville, MD 2004-Sept 2006
Clinical consultant
to the :tvficrobiology and Chemistry divisions in the Office of In Vitro Diagnostic Device
Evaluation and Safety in the Center for Devices and Radiological Health at the
Food and Drug
Administration. This division evaluates and clears infectious disease and chemistry in vitro diagnostic
devices. Appointed
as the Oirector of the Patient Safety Committee, which monitors safety of devices in
post marketing.
Attending Physician Washington, DC 4-\pr. 2004 to date
Well baby nursery and special care nursery attending physican. Admitting, discharging ,and identifying
neonates
at risk for illness and congenital health issues. Credentialed at Sibley and Georgetown University
Hospitals.
Attending Physician Washington, DC
Children's Health Project
of DC pediatrician working in medically underserved areas ofWashington, DC.
EDUCATION
Johns Hopkins University Medical Center Baltimore, MD 2001-2003 Resident in Preventive Medicine. Successfully completed rotations at Occupational Safety and Health
Administration (OSHA) Dept.
of Occupational Medicine); the District of Columbia Dept. of Health
(Division
of Communicable Diseases); the US Food and Dtug Administration (FDA, Dept. of Vaccine
Safety, Smallpox Vaccine Surveillance Team); the Department
of Juvenile Justice (DJJ) Health division;
and the
\XIHO /JHU dept. of Infectious Diseases in Cameroon on measles surveillance and prevention.
Johns Hopkins University Baltimore, MD 2001-2003
Completed a.Masters
in Public Health during the preventive medicine residency specializing in Health Policy
and Management.
Georgetown University Washington, DC 2000-2002
Clinical Pha1macology Fellowship. Trained extensively in drug interaction, metabolism and the specialty
of
drug management. Focused on Natural Products. Conducted clinical trial on effect of St. John's Wort on
CYP450 Isoenzyrnes.
Georgetown University Hospital Washington, DC 1997-2000
Resident in Pediatrics. Electives completed during residency included; Pediatric Gastroenterology, Pediatric
Infectious Diseases,
Pediat11c Cardiology (Fairfax Hospital, VA), Pediatric Endocrinology (Howard
University Hospital,DC), Child Advocacy (DC Action for Children), Pediatric Development
(PG Hospital,
MD), International Medicine (Mulago Hospital, Kampala, Uganda).
Temple University School of Medicine
Doctor of Medicine Degree
Philadelphia, PA
Cornell University Ithaca, NY
Bachelors of Science Degree, majored in Nut.ritional Biochemistry.
Philadelphia High School for Girls
Received High School diploma
Shaw High School
RESEARCH EXPERIENCE
Philadelphia, PA
Cleveland,
0 H
Bill Gates Foundation/Johns Hopkins University Yaounde, Cameroon
1993-1997
1987-1989
1985-1987
June-Sept. 2003
Worked with local branch
of the \VI-IO and the Cameroon national vaccine program (PEV) to evaluate the
effectiveness
of the country's measles infectiort surveillance system. Prov"ided recomtnendations to the
Cameroonian Ministry
of Public Health and provided data to JHU to help determine the accuracy of data
generated by
PEV /\XIHO. Traveled extensively through Cameroon.
Food and Drug Administration Rockville, MD Feb-Mar., 2003
Analysis
of adverse events reported to VAERS for the Smallpox Vaccine from December 13, 2002-March
2003. Findings were presented to the CDC and
FDA vaccine safety teams as well as to a Congressional
Subcommittee. Advisor: Robert Ball, MD.
Georgetown University Hospital Washington, DC 2001-2003
Effect
ofSt. John's Wort Extract on CYP450 Isoenzymes and Natural Product use in the Pediatric
population
Case Western Reserve School of Medicine
DNA Transplarttation
Clevehrnd,
0 H Summer, 1992 Temple University School of Medicine Philadelphia, P21. Summer,1991
DNA sequencing of Retinoic Acid Binding Protein. Advisor: Diane Soprano, PhD
Temple University School of Medicine Philadelphia, P.A Summer, 1988
Replication
of neonate cardiocytes using Norepinephrine Advisor: Thomas Marino, PhD.
PUBLICATIONS
Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices, CDRH Guidance
document, Issuance Pending Spring, 2015
http:/ /W\vw.fda.gov/ucm/groups/fdagov-public/@fdagov-1neddev
gen/ documents/ document/ ucm444591.pdf
Pediatric Clinics
of North America, Safety and Reliability in Pediatrics, "FDA working to ensure the safety of
medical devices used in the pediatric population". Volume 59, Issue 6, December 2012, Pages 1355-1366.
http://www.sciencedirect.com/science/article/pii/S0031395512001307
OTHER ACTIVITIES
Cornell Human Ecology Alumni Association Ithaca, NY 2010 to 2015
Elected
in 2009 to serve as member of the Board of Directors for HE.A,-\. Participates in quarterly meetings
either
on campus or by telephone to discuss issues related to the college of Human Ecology, and serving on the
committee, which reviews HE.A.A Student
Grant applications.
Unity Health Care Washington, DC 2010 to 2015
Serving
on the Board of Directors of Unity Health Care, which is a DC, based health care conglomerate,
which provides medical
and social services to DC residents regardless of ability to pay. ~-\.ttends monthly BOD
meetings. Chair of Continuous Quality Improvement Committee since 2012)
Step Mrika! Washington, DC 2008 to date
Se.ryed
on the planning committee for the Annual Home Performance Series and currently serving on the
Board of Directors as Chairperson. Served as Vice-Chair of the BOD 2010-2011 and Chair of the BOD
from 2012-2017.
FRESH Student ExtemProgram Washington, DC 2007-2010
Scheduled profe.ssional shadowing experience with current Cornell Student during academic breaks.
Cornell Alumni Student Mentoring Program 2006 to date
Virtual
mentor to two currently enrolled Cornell students and three recent alumni. Visit with students either
on campus or in DC to serve as mentor and advisor. Currently Serving as mentor to S Cornell Alumni.
Mayor Fenty's Health Policy Transition Team Washington, DC 2006-2007
Served
on the Health Policy Transition team From November, 2006-February, 2007 for DC J\,1ayor Adrian
Fenty
and assisted in the drafting of '~The Parameters of Health" which outlined health policy proposals and
priorities
to achieve .Adrian Fenty's ''Vision for a Healthy City".
Cornell Club of Washington
Board Member
Washington,
DC 2005-2006 Cornell Black Alumni Associatiort Washington, DC 2004-2011
Member. Served as Reg1onal Co-Chair
in 2006.
Institute for Urban Living Washington, DC 2004-2006
Member of the Board of Directors. Organization provides support services for the District's homeless
population.
College Bound Washington, DC 2001-2016
Tutot and mentor. Selected as Mentor of the Year, 2003. Nominated for 111e Washington Redskins
Community Quarterback.Award. Currently serving
on the Board of Directors (2006-to date) as Board
Secretary (since 2012) ..
Also serving as a virtual mentor to a college graduate.
Cornell Alumni Ambassadors Admissions Network Washington, DC
Inte.rview prospective applicants to Cornell and participate in college fairs.
1995-to date
Manuscript Reviewer Washington, DC 2001-to date
Review manuscripts
on behalf of ~iichael Stein, MD for Clinical Pharmacology and Therapeutics scientific
journal.
Dream Academy
Mentor
SAT prep class instructor
Big Friends
Tutored third and fourth grader students
HONORS AND ACHIEVEMENTS
Washington, DC
Philadelphia, PA
Philadelphia, PA
2000-2002
1994-1997
1993-1995
ODE Award of Recognition June 2017
This award recognized tireless efforts to expedite
the classification of unclassified wound dressings and to
prepare for progress briefings to Center and Agency management.
ODE Award of Recognition June 10, 2017
This award recognized excellence in Agency "vide collaboration to promote safe use of soft tissue filler devices.
ODE Award of Recognition August 2016
This award r.ecognized excellence in consults
and development and dissemination of policies related to devices
intended for pediatric use.
ODE Award of Recognition August 2015
This
award recognized excellence in consults and regulatory support and was awarded by the ODE Office
director.
Commissioner's Award ofExcellence August, 2014
This award recognized contributions
and accomplishments in conducting and executing the Pediatric Device
Consortia
Grant process.
ODE Excellence in Premarket Review Team Award July 2014
This award recognized significant accomplishment in supporting the mission of CDRH in working with the
Aesthe.tic Clinical Trials Team.
CDRH Guidance/Policy/Regulation Development Excellence Award June, 2014
For excellence in writing guidance on custom devices that incorporates the requirements and revisions of the
FDA Safety and Innovations Act of 2012. FDA Ho11or Award J1.1ne, 2014
This award recognized superior achievement
of the Agency's mission through teamwork, partnership, shared
responsibility,
o:r fostering collaboration and coalition to achieve F DA goals related to the planning ancl
implementation of the Rare Disease Public Workshop.
Reward and Recognition FDA/CDRH/ODE August 2011
For exceptional scientific and regulatory perfo1mance while reviewing two de novo applications.
Reward and Recognition FDA/CDRH/0D E August 2011
For exceptional scientific and regulatory performa11ce, while reviewing Contura, Inc's Aquamid Dermal Filler
PM.A.
Reward and Recognition FDA/CDRH/ODE August2011
For exceptional scientific and regulatory performance during the preparation and editing of modifications to
the Breast Implant patient and physician labels to include .ALCL information.
Reward and Recognition FDA/CDRH/ODE Sept. 2010
For exceptional scientific and regulatory perfo1mance while acting as clinical reviewer and medical advisor to
the breast implant review team for bteast implant PfvL\s and medical issues related to breast implants.
FDA Outstandiilg Service Award June, 2010
This award is in recognition
of dedication to excellence in accomplishing the mission of the CDRH as a
member of the Wound Dressing Group.
Reward and Recognition FDA/CDRII/ODE Sept. 2009
For work on perfo,;ming complicated review of tiss1.1e fillers combined with the drug lidocaine.
Director's Special Citation., FDA/CDRH/OSB
Recognized for work on the launch of the KidNet pilot program
Special Recognition Award, FDA/CDRH/OIVD
Recognition for work with the review team for Continuous Glucose Monitors
Group Recognition Award, FDA/CDRH/OSB
Recognition for work with the Collaborative Reviewers Team.
June, 2008
June,2008
June,2008
Reward and Recognition FDA/CDRH/ODE March, 2005
For medical consulting contributions to the review of In Vitro diagnostic Devices and Leadership of the
OIVD Patient Safety Team.
Bill Gates FoUildation Grant
NIH Fellowship Award
National Minority Fellowship Award
Quill and
Dagger Senior Honor Society
Cornell Tradition Fellowship
Office
of Minority Affairs Scholarship
White Williams Scholarship
for In.t.ernational Affairs
.ADMITTING PRIVLIGES
2003
2001-2002
1994-1997
1992
1990-1993
1989-1993
1988-1989 Georgetown University Hospital and Sibley IV1emorial Hospital. * * * WE ARE
WASl-!INGTON
oc
Executive Office of the Mayor -Office of Talent and Appointments
John A. Wilson Building I 1350 Pennsylvania Avenue, Suite 600 I Washington, DC 20004
"""4~1: ...... o11~
,.~
Dr. Jacqueline Francis, MD
Dr. Jacqueline Francis is a pediatrician and Medical Officer at the Food
and Drug Administration (FDA). She has been a member
of the Child
Fatality Review Committee since 2017.
Dr. Francis began her career
in the FDA's Office ofln-Vitro Diagnostic
Devices, where she worked
in the microbiology branch as a clinical
consultant.
In her current office, the Office of Device Evaluation in the
Division
of Surgical Devices, she specializes in policy, regulation, and
clinical protocol design
of plastic and reconstructive surgery devices as
well as pediatric devices. Dr. Francis also serves as an Attending
Physician with the KIDS Mobile Clinic
of Medstar Hospital and
previously served at the Hoya Clinic, which serves the shelter patients
at DC General Campus.
A Ward 6 resident, Dr. Francis received a Bachelor
of Science in Nutritional Biochemistry from
Cornell University, a Doctor
of Medicine from the Temple University School of Medicine, and a
Master
of Public Health from the Johns Hopkins University Bloomberg School of Public Health.
* * * GOVERNMENT OF THE DISTRICT OF COLUMBIA
E~ecutive Office of Mayor Muriel Bowser
* * * WEARE
WASI-IINGTON
oc
Office of the General Counsel to the Mayor
To:
From:
Date:
Subject:
Tommy Wells, Steve Walker
Betsy Cavendish
April
5, 2023
Legal sufficiency review of Resolutions nominating Dr. Jacqueline Francis, Dr.
Cheryl Williams and Kristen Constantine as community representative members
of the Child Fatality Review Committee
This is to Certify that this office has reviewed the above-referenced resolution and
found it to be legally unobjectionable. If you have any questions in this regard, please do not
hesitate to call Vanessa Careiro, Deputy General Counsel, Executive Office of the Mayor, at
202-724-1303, or me at 202-724-7681.
Elizabeth
A. (Betsy) Cavendish
The John A. Wilson Building • 1350 Pennsylvania Avenue, NW • Suite 300 • Washington, D. C. 20004 • Office (202) 724-7681